IDXX logo

IDEXX Laboratories, Inc.NasdaqGS:IDXX Stock Report

Market Cap US$53.1b
Share Price
US$653.95
My Fair Value
US$691
5.4% undervalued intrinsic discount
1Y34.7%
7D0.6%
Portfolio Value
​
View

IDEXX Laboratories, Inc.

NasdaqGS:IDXX Stock Report

Market Cap: US$53.1b

IDEXX Laboratories (IDXX) Stock Overview

Develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. More details

IDXX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends0/6

Rewards

Earnings are forecast to grow 9.13% per year

Earnings have grown 10.3% per year over the past 5 years

Risk Analysis

Has a high level of debt

Significant insider selling over the past 3 months


IDXX Community Fair Values

Create Narrative

See what 44 others think this stock is worth. Follow their fair value or set your own to get alerts.

IDXX logo
IDEXX Laboratories

Global Pet Ownership And AI Diagnostics Will Expand Market Opportunities

Key Takeaways Strong adoption of innovative diagnostics and software ecosystem is accelerating recurring revenue growth, margin expansion, and customer retention beyond expectations. International growth and industry leadership in AI-enabled preventive care position the company to substantially expand its addressable market and gain operating leverage.
View narrative
US$785.00
FV
16.7% undervalued intrinsic discount
9.43%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 3 hours ago author updated this narrative
IDXX logo
IDEXX Laboratories

Advanced Diagnostics And International Expansion Will Define Future Opportunity

Key Takeaways Expansion in innovative diagnostic platforms and international markets is driving recurring revenue growth, margin expansion, and enhanced geographic diversification. Strong customer retention and broader adoption of cloud solutions create stable, high-margin revenue streams and position the company for sustained long-term earnings growth.
View narrative
US$691.18
FV
5.4% undervalued intrinsic discount
8.76%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
1 day ago author updated this narrative
IDXX logo
IDEXX Laboratories

Declining Pet Ownership And Rising Compliance Costs Will Erode Margins

Key Takeaways Demographic shifts and economic pressures are shrinking the addressable market, suppressing demand for premium diagnostics, and limiting revenue and margin growth. Rising competition, market saturation, and regulatory hurdles could erode pricing power, slow recurring sales, and increase costs, challenging the company's profitable growth model.
View narrative
US$454.14
FV
44.0% overvalued intrinsic discount
7.65%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
6 days ago author updated this narrative
View Stock Community

IDEXX Laboratories, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for IDEXX Laboratories
Historical stock prices
Current Share PriceUS$653.95
52 Week HighUS$688.12
52 Week LowUS$356.14
Beta1.5
1 Month Change24.17%
3 Month Change26.22%
1 Year Change34.69%
3 Year Change74.50%
5 Year Change70.60%
Change since IPO69,078.22%

Recent News & Updates

IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 07
IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Recent updates

IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 07
IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

At US$532, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Jul 23
At US$532, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable

May 11
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Compensation Looks Acceptable To Us And Here's Why

May 01
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Compensation Looks Acceptable To Us And Here's Why

Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$427 Based On Its Intrinsic Value?

Apr 24
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$427 Based On Its Intrinsic Value?

IDEXX Laboratories: I Love The Business, Not The Stock Price

Apr 14

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

Mar 30
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

IDEXX Laboratories: A Top Dog In The Pet Care Market

Mar 12

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Business Is Yet to Catch Up With Its Share Price

Feb 27
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Business Is Yet to Catch Up With Its Share Price

IDEXX Laboratories And Its Real Value

Feb 10

Calculating The Fair Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Jan 13
Calculating The Fair Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

Dec 26
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly

At US$420, Is It Time To Put IDEXX Laboratories, Inc. (NASDAQ:IDXX) On Your Watch List?

Nov 19
At US$420, Is It Time To Put IDEXX Laboratories, Inc. (NASDAQ:IDXX) On Your Watch List?

IDEXX Laboratories Q3: Weak End-Market Demand Continues

Nov 11

Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects

Oct 28
Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Oct 15
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

Sep 18
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Sep 05
A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?

Aug 20
What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?
author-image

Global Expansion And Innovative Products Propel Revenue And Margin Growth Amidst Challenges

IDEXX's international and innovative product growth, like the inVue Dx Cellular Analyzer, fuels potential revenue and market share increases globally.

IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits

Aug 12

Looking For Fast Growth In Healthcare? IDEXX Has You Covered

Jun 28

IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)

Apr 08

IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified

Jan 16

Shareholder Returns

IDXXUS Medical EquipmentUS Market
7D0.6%1.2%1.6%
1Y34.7%6.1%17.4%

Return vs Industry: IDXX exceeded the US Medical Equipment industry which returned 7.9% over the past year.

Return vs Market: IDXX exceeded the US Market which returned 19.4% over the past year.

Price Volatility

Is IDXX's price volatile compared to industry and market?
IDXX volatility
IDXX Average Weekly Movement8.6%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.4%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market3.1%

Stable Share Price: IDXX has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: IDXX's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198311,000Jay Mazelskywww.idexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits.

IDEXX Laboratories, Inc. Fundamentals Summary

How do IDEXX Laboratories's earnings and revenue compare to its market cap?
IDXX fundamental statistics
Market capUS$53.12b
Earnings (TTM)US$985.66m
Revenue (TTM)US$4.04b
53.1x
P/E Ratio
13.0x
P/S Ratio

Is IDXX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IDXX income statement (TTM)
RevenueUS$4.04b
Cost of RevenueUS$1.55b
Gross ProfitUS$2.48b
Other ExpensesUS$1.50b
EarningsUS$985.66m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 03, 2025

Earnings per share (EPS)12.32
Gross Margin61.54%
Net Profit Margin24.41%
Debt/Equity Ratio75.7%

How did IDXX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/14 10:49
End of Day Share Price 2025/08/14 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IDEXX Laboratories, Inc. is covered by 30 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Ishan MajumdarBaptista Research
Navann Ty DietschiBNP Paribas Exane